These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9926000)

  • 21. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
    Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction.
    Denniss AR; Richards DA; Taylor AT; Uther JB
    Basic Res Cardiol; 1989; 84(1):5-12. PubMed ID: 2923606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
    Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of E4031, a class III antiarrhythmic drug, on ischemia- and reperfusion-induced arrhythmias in isolated rat hearts.
    Shinmura K; Tani M; Hasegawa H; Ebihara Y; Nakamura Y
    Jpn Heart J; 1998 Mar; 39(2):183-97. PubMed ID: 9687827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
    Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
    Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between antiarrhythmic drugs and cardiac memory.
    Plotnikov AN; Shvilkin A; Xiong W; de Groot JR; Rosenshtraukh L; Feinmark S; Gainullin R; Danilo P; Rosen MR
    Cardiovasc Res; 2001 May; 50(2):335-44. PubMed ID: 11334837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of epinephrine on the electrophysiologic properties of Purkinje fibers surviving myocardial infarction.
    Cameron JS; Dersham GH; Han J
    Am Heart J; 1982 Sep; 104(3):551-60. PubMed ID: 7113895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between refractory period and conduction time of the AV node under various cycle lengths in the canine heart. The significance of wavelength and excitable gap in reentrant tachycardia.
    Segawa K
    Jpn Heart J; 1996 May; 37(3):373-82. PubMed ID: 8774630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
    Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salutary antiarrhythmic effect of combining a K channel blocker and a beta-blocker in a canine model of 7-day-old myocardial infarction.
    Takatsuki S; Mitamura H; Kanki H; Sueyoshi K; Ogawa S
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):914-8. PubMed ID: 10836726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of verapamil against ventricular arrhythmias induced by programmed electrical stimulation in the late myocardial infarction phase in dogs.
    Krejcy K; Krumpl G; Todt H; Raberger G
    J Pharm Pharmacol; 1992 Apr; 44(4):349-54. PubMed ID: 1355549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of procainamide on the postrepolarization refractoriness in cardiac muscle: evaluation using the block coupling interval in the artificial isthmus model in the canine right atrium.
    Yoshizawa N; Niwano S; Moriguchi M; Kitano Y; Inuo K; Saito J; Izumi T
    Pacing Clin Electrophysiol; 2001 Jul; 24(7):1100-7. PubMed ID: 11475826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction.
    Xing Y; Chen J; Wang J; Gao Y; Niu W; Zhao M; Zhu H; Guo L; Lu P; Wang S
    J Ethnopharmacol; 2012 Jun; 141(2):674-84. PubMed ID: 21924334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiological effects of berbamine on ischemic ventricular tachyarrhythmia].
    Guo ZB; Cao HY; Xu Z; Li Q
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):44-7. PubMed ID: 1950584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes.
    Yamamoto K; Bando S
    Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial contractile behavior of a new sotalol derivative.
    Cingolani HE; Wiedmann RT; Lynch JJ; Baskin EP; Stein RB
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):83-9. PubMed ID: 1708061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a novel class III antiarrhythmic agent, E-4031, on reentrant tachycardias in rabbit right atrium.
    Adaniya H; Hiraoka M
    J Cardiovasc Pharmacol; 1990 Jun; 15(6):976-82. PubMed ID: 1694921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sympathetic denervation of the epicardial border zone in the genesis of dispersion of refractoriness and arrhythmogenesis in a 7-day-old canine myocardial infarction model.
    Saeki K; Ogawa S; Sadanaga T; Yoh S; Furuno I; Nakamura Y
    Coron Artery Dis; 1993 Sep; 4(9):775-82. PubMed ID: 8287211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic and electrophysiologic effects of MDL 11,939, a novel class III antiarrhythmic agent in anesthetized dogs.
    Koerner JE; Dage RC
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):383-93. PubMed ID: 1700208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.